促进癌症幸存者的全球优先事项
Henry C Y Wong1, Nicolas H Hart2,3, Alexandre Chan4,5
1Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, Hong Kong S.A.R., China.
Current opinion in oncology
|February 18, 2026
概括
在全球范围内改善癌症幸存者护理需要专注于公平获取和多样化的患者需求. 实施多学科团队和技术驱动的干预措施对于全球更好的结果至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 癌症幸存者在癌症治疗中越来越关注,但全球范围内获得优质服务的机会不均.
- 根据癌症类型和患者人口统计数据,生存需求有很大差异,包括老年人和晚期疾病患者.
研究的目的:
- 确定提高全球癌症幸存者护理的重点优先事项.
- 解决在获取,弱势群体的结果和新护理模式的整合方面的差异.
主要方法:
- 本综述综合了有关癌症幸存者护理挑战和解决方案的当前知识.
- 它探讨了多学科团队,数字健康和人工智能的作用.
- 它考虑了IPOS和MASCC等国际组织的调查结果.
主要成果:
- 癌症幸存者面临着独特的挑战,特别是老年人和患有晚期癌症的人.
- 多学科护理模式提高了生活质量,降低了成本,尽管瘤学家主导的随访仍然占主导地位.
- 数字健康和人工智能为增强监测和个性化护理提供了潜力.
- 在支持性护理的获取和指导方针的实施方面,仍然存在显著的差异,特别是在低收入和中等收入国家.
结论:
- 推进幸存者护理需要在研究和政策中嵌入公平.
- 扩大跨学科和技术支持型号,以及全球合作是必不可少的.
- 纵向研究,量身定制的指导方针和在资源有限的环境中能力建设对于优化幸存者的结果至关重要.
相关概念视频
Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K

